However, some people find that having a light, healthy snack before the injection helps settle their stomach
Interestingly, growing evidence suggests that GLP-1RAs reduce systemic inflammation beyond local antiinflammatory effects in atherosclerotic plaques
Biggest shake-up in type 2 diabetes care in a decade announced
Semaglutide and tirzepatide are FDA-approved with extensive clinical trial data showing average 15-20% body weight loss, improvements in cardiovascular health markers, reduction in obesity-related disease risk, and excellent safety profile with proper medical supervision
EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis: 2023 update
These rising trends may be influenced by local health care access, demographics, or public conversations around weight loss